Cats and Their Allergenic Challenges

The Allure of Big Cats

Cats are fascinating creatures, particularly the majestic large ones found on the savannah. Their predawn roars herald a new day across Africa, captivating many. In contrast, smaller domestic cats tend to be friendlier companions. However, for the ten to twenty percent of the population afflicted with cat allergies, these felines present unique challenges. Symptoms such as sneezing, watery eyes, and asthma can quickly disrupt social gatherings, especially if a cat, like Mr. Whiskers, enters the room.

A Hypoallergenic Solution: Meet Alsik

Fortunately, advancements in science may offer relief for allergy sufferers. Researchers have developed a hypoallergenic cat named Alsik, the world’s first cat engineered to be allergen-free. This groundbreaking achievement was reported by a team at Gyeongsang National University in South Korea and published in *Scientific Reports* in 2024. The scientists utilized gene-editing technology to remove both copies of the CH2 gene from a domestic cat. This gene is responsible for producing the Fel d 1 protein, which accounts for 90% of cat allergies in humans.

The Fel d 1 Protein and Its Implications

The Glitter Problem

The Fel d 1 protein is notoriously difficult to eliminate, similar to glitter; it spreads easily and can persist on surfaces for months. While scientists are still exploring its exact purpose in feline communication, breeders have attempted to minimize its presence through selective breeding. Breeds such as Siberians, Balinese, and Russian Blues are known to produce lower levels of this protein, but none have entirely eradicated it.

CRISPR-Cas9 Technology in Action

Under the guidance of Professor Il-Keun Kong, the research team employed the CRISPR-Cas9 gene-editing technique to target the Fel d 1 protein’s gene. This Nobel Prize-winning technology allows for precise modifications in an organism’s DNA, enabling the deletion of specific genes. In this case, the team successfully deleted a crucial gene segment from the cat genome.

The Birth of Hypoallergenic Kittens

Creating Alsik

The researchers treated twenty feline embryos with gene-editing technology and implanted them into surrogate mothers. Two kittens were born: a female named Haemi and a male named Heavy. Haemi possessed one normal and one edited gene, while Heavy was classified as a mosaic, showcasing both normal and altered tissues. The team was curious whether Heavy could pass on the gene modification to his offspring.

Haemi’s Litter and Discovery

Over time, Haemi became pregnant with Heavy’s kittens, resulting in a litter of four. The genetic analysis revealed that one kitten had inherited the gene deletion from both parents, leading to the birth of Alsik, the first truly hypoallergenic cat.

Testing Alsik’s Allergen Levels

The Deglittering Process

To determine Alsik’s ability to produce the Fel d 1 protein, the researchers first had to cleanse him of any residual allergens. He received a bath with hypoallergenic soap to remove traces of the protein from his mother. Typically, domestic cats harbor about 16 µg/ml of Fel d 1; however, following his bath, Alsik’s levels dropped to less than 1% of that amount. After weeks of isolation, Alsik exhibited nearly undetectable levels of the protein in both his saliva and skin.

Cloning for Consistency

To verify if Alsik’s hypoallergenic traits were consistent, scientists cloned him, resulting in the birth of Alsik C. After undergoing the same cleansing procedure, Alsik C demonstrated similarly low levels of Fel d 1, indicating that the gene modification was stable within this lineage.

The Future of Hypoallergenic Cats

Potential Impact on Allergy Sufferers

This research extends beyond the novelty of designer pets. For many, cat allergies can lead to serious respiratory issues, making them a significant health concern. The ultimate aim of this research is to develop a gene therapy that can be applied to any domestic cat living with an allergy-prone individual. Future studies will focus on clinical trials to ensure the safety and well-being of these gene-edited cats.

Looking Ahead

The development of hypoallergenic female cats will be crucial for expanding the trial population. While not every cat will require gene therapy, the prevalence of cat allergies suggests a considerable market for individuals wishing to enjoy pet companionship without adverse reactions.

As I reflect on this progress, I am reminded of the majestic felines that roam the African savannah, pondering whether they too harbor the same allergens that challenge so many.

References

Lee, S.R., Lee, KL., Song, SH. et al. Generation of Fel d 1 chain 2 genome-edited cats by CRISPR-Cas9 system. Sci Rep 14, 4987 (2024).